Advertisement

IVIS Spectrum CT to Image the Progression of Pneumococcal Infections In Vivo

  • Adam Sierakowiak
  • Birgitta Henriques-Normark
  • Federico IovinoEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1968)

Abstract

Imaging through the IVIS Spectrum CT system does not provide the resolution at cellular level like the high-resolution or super-resolution microscopy. Rather, it detects bacterial infections in specific anatomical compartments/organs of the animals. The IVIS Spectrum imaging system is a unique imaging technology that allows for real-time monitoring of disease progression in living animals through the use of either bioluminescent or fluorescent probes.

Key words

Real-time In vivo imaging IVIS Bioluminescence Fluorescence 3D modeling 

References

  1. 1.
    Poussard A, Patterson M, Taylor K et al (2012) In vivo imaging systems (IVIS) detection of a neuro-invasive encephalitic virus. J Vis Exp 70:e4429Google Scholar
  2. 2.
    Chen H, Thorne SH (2012) Practical methods for molecular in vivo optical imaging. Curr Protoc Cytom 59:12–24PubMedPubMedCentralGoogle Scholar
  3. 3.
    Iovino F, Engelen-Lee JY, Brouwer M (2017) pIgR and PECAM-1 bind to pneumococcal RrgA and PspC mediating bacterial invasion of the brain. J Exp Med 214:1619–1630CrossRefGoogle Scholar
  4. 4.
    Iovino F, Thorsdottir S, Henriques-Normark B (2018) Receptor blockade: a novel approach to protect the brain from pneumococcal invasion. J Infect Dis 218(3):476–484.  https://doi.org/10.1093/infdis/jiy193CrossRefPubMedGoogle Scholar
  5. 5.
    Orihuela CJ, Gao G, Francis KP (2004) Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 190:1661–1669CrossRefGoogle Scholar
  6. 6.
    Ravensdale J, Wong Z, O’Brien F (2016) Efficacy of antibacterial peptides against peptide resistant MRSA is restored by permeabilization of bacteria membranes. Front Microbiol 7:1745CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Adam Sierakowiak
    • 1
  • Birgitta Henriques-Normark
    • 2
    • 3
    • 4
  • Federico Iovino
    • 2
    • 3
    Email author
  1. 1.Department of Oncology-PathologyKarolinska Institutet and Karolinska University HospitalStockholmSweden
  2. 2.Department of Microbiology, Tumor and Cell BiologyKarolinska Institutet, BioclinicumStockholmSweden
  3. 3.Department of Clinical MicrobiologyKarolinska University HospitalStockholmSweden
  4. 4.Singapore Centre on Environmental Life Sciences Engineering (SCELSE), and Lee Kong Chian School of Medicine (LCK)Nanyang Technological University (NTU)SingaporeSingapore

Personalised recommendations